Metabolic 99%+

GLP-3 (RT) 10mg

GLP-3 (RT) is a tri-agonist research compound that simultaneously targets GLP-1, GIP, and glucagon receptors, making it one of the most studied metabolic peptides currently in research. Supplied as a lyophilized powder in a 10mg vial, ready for reconstitution.

Purity: >99% (HPLC Verified) | Form: Lyophilized Powder | Storage: −20°C recommended

For in-vitro laboratory research use only. Not for human consumption, medical use, or diagnostic purposes. Not evaluated by the FDA.

Select Your Pack

1 Vial

GLP-3 RT 10mg · Single

$79.99

Best Value

3 Vials

20% Off

$67 / vial · Best Value

$199.99

99%+Purity

LabCertified

SameDay Ship

Accepted: VISA AMEX DISC

Research Use Only

This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.

Important Notice

All compounds are sold individually and do not include research supplies. Products are provided in lyophilized (powder) form and require proper reconstitution before use in research settings.

Common Questions

Frequently Asked About GLP-3 (RT)

GLP-3 (RT) simultaneously activates GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and glucagon receptors. This triple-agonist mechanism is what distinguishes it from dual agonists like tirzepatide, which targets only GLP-1 and GIP.

After reconstitution, store at 2–8°C (refrigerated) for up to 4–6 weeks, or at −20°C for up to 6 months. Do not refreeze after thawing. Lyophilized (dry powder) form is stable at −20°C for up to 24 months when kept sealed and dry.

GLP-3 (RT) has a molecular weight of approximately 4,751.4 g/mol and consists of 39 amino acid residues. Its molecular formula is C₁₉₄H₃₀₁N₅₃O₅₈. It is classified as a long-acting synthetic peptide analogue.

GLP-1 mono-agonists (like semaglutide) target only one receptor. GLP-3 (RT)'s additional GIP and glucagon receptor activity is hypothesized to provide complementary effects on fat oxidation, energy expenditure, and hepatic glucose regulation, areas that GLP-1 alone does not directly address.

Yes. Every batch of GLP-3 (RT) shipped by PepLab.us is accompanied by a Certificate of Analysis from an independent third-party laboratory. COAs are accessible on our Test Results page by batch number.

Technical Specifications

Compound Information

Chemical Profile

Molecular Formula	C₁₉₄H₃₀₁N₅₃O₅₈
Molecular Weight	4,751.4 g/mol
Amino Acid Count	39 residues
Classification	Synthetic peptide analogue
Receptor Targets	GLP-1, GIP, Glucagon
Form Supplied	Lyophilized powder
Purity (HPLC)	>99%

Storage & Stability

Condition	Duration	Status
Lyophilized, −20°C	24 months	✓ Stable
Lyophilized, 2–8°C	3 months	✓ Stable
Reconstituted, 2–8°C	4–6 weeks	✓ Stable
Reconstituted, −20°C	6 months	✓ Stable

Citations

Sources & References

Research references cited on this page are sourced from peer-reviewed publications. Links open external research databases.

GIP, GLP-1 and Glucagon Receptor Agonist for People with Type 2 Diabetes

Jastreboff AM et al. · N Engl J Med · 2023

GIP, GLP-1 and Glucagon Receptor Triple Agonism: Mechanisms and Metabolic Effects

Liu L et al. · J Endocrinol · 2023

Beyond GLP-1: New Targets for Obesity and Metabolic Disease Research

Min T, Bain SC · Drugs · 2021

Cardiovascular and Metabolic Effects of Triple Receptor Agonism in Preclinical Research Models

Hartman ML et al. · Diabetes Obes Metab · 2023

You Must Be 18+ to Enter

GLP-3 (RT) 10mg

Related Products

Tirzepatide (10mg)

AOD-9604 (5mg)

KLOW Blend (80mg)

5-Amino-1MQ (50mg)